Pregled bibliografske jedinice broj: 676755
Germline BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia : Identification of three novel mutations
Germline BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia : Identification of three novel mutations // European Journal of Cancer 48 (2012) (S5) / EACR (ur.).
Amsterdam: Elsevier, 2012. str. S274-S275 doi:10.1016/S0959-8049(12)71739-2 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 676755 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Germline BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia : Identification of three novel mutations
Autori
Musani, Vesna ; Levačić Cvok, Mirela ; Sušac, Ilona ; Sabol, Maja ; Ozretić, Petar ; Car, Diana ; Eljuga, Damir ; Levanat, Sonja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Journal of Cancer 48 (2012) (S5)
/ EACR - Amsterdam : Elsevier, 2012, S274-S275
Skup
22nd Biennial Congress of the European Association for Cancer Research (22 ; 2012)
Mjesto i datum
Barcelona, Španjolska, 07.07.2012. - 10.07.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Germline mutations ; BRCA1/BRCA2 ; breast/ovarian cancer
Sažetak
Breast cancer is the most commonly diagnosed cancer inwomen after non-melanoma skin cancer, and is the leading cause of cancerrelated deaths in Croatia. Ovarian cancer is in the fifth place, both in incidenceand mortality. About 5−15% of breast cancer and 10% of ovarian cancer casesare hereditary, and germline mutations inBRCA1andBRCA2genes accountfor the majority of hereditary breast and ovarian cancers. The purpose of thisstudy was to estimate the incidence and spectrum of pathogenic mutations inBRCA1/2genes in high risk women in Croatia. This study was funded by TheTerry Fox Run 2009 donation and supported by The Terry Fox Foundation andCroatian League Against Cance
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
Napomena
Abstracts of the 22nd Biennial Congress of the European Association for Cancer Research.
POVEZANOST RADA
Projekti:
098-0982464-2461 - Prijenos signala u tumorima: Hh-Gli put, interakcije i potencijalne terapije (Levanat, Sonja, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Petar Ozretić
(autor)
Vesna Musani
(autor)
Sonja Levanat
(autor)
Diana Trnski
(autor)
Maja Sabol
(autor)
Poveznice na cjeloviti tekst rada:
doi www.ejcancer.com www.ejcancer.com doi.org www.sciencedirect.comCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus